| Hyperprogression under immune checkpoint-based immunotherapy—current understanding, the role of pd-1/pd-l1 tumour-intrinsic signalling, future directions and a potential large … M Kocikowski, K Dziubek, M Parys Cancers 12 (4), 804, 2020 | 22 | 2020 |
| Design, synthesis and biological evaluation of PD-1 derived peptides as inhibitors of PD-1/PD-L1 complex formation for cancer therapy M Bojko, K Węgrzyn, E Sikorska, M Kocikowski, M Parys, C Battin, ... Bioorganic Chemistry 128, 106047, 2022 | 13 | 2022 |
| Development of monoclonal antibodies targeting canine PD-L1 and PD-1 and their clinical relevance in canine apocrine gland anal sac adenocarcinoma L Minoli, L Licenziato, M Kocikowski, M Cino, K Dziubek, S Iussich, ... Cancers 14 (24), 6188, 2022 | 8 | 2022 |
| Analysis of venom sac constituents from the solitary, aculeate wasp Cerceris rybyensis S Kote, J Faktor, I Dapic, MY Mayordomo, M Kocikowski, A Kagansky, ... Toxicon 169, 1-4, 2019 | 5 | 2019 |
| Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1. 2 monoclonal antibody L Uhrik, L Hernychova, P Muller, U Kalathiya, MM Lisowska, ... Biochemical Journal 478 (1), 99-120, 2021 | 3 | 2021 |
| Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation JR O'Neill, MY Mayordomo, G Mitulović, S Al Shboul, G Bedran, J Faktor, ... Molecular & Cellular Proteomics 23 (6), 2024 | 1 | 2024 |
| Investigation of tumor intrinsic PD1/PD-L1 in canine urothelial carcinomas as a spontaneous translational model for human invasive bladder cancer YJ Wang, K Pietrzak, M Kocikowski, D Argyle, T Hupp, M Parys Cancer Research 79 (13_Supplement), 3972-3972, 2019 | 1 | 2019 |
| Comparative characterization of two monoclonal antibodies targeting canine PD-1 M Kocikowski, K Dziubek, K Węgrzyn, V Hrabal, F Zavadil-Kokas, ... Frontiers in Immunology 15, 1382576, 2024 | | 2024 |
| Barking Up the Right Tree: Immune Checkpoint Signatures of Human and Dog Cancers M Kocikowski, M Yebenes Mayordomo, JA Alfaro, M Parys bioRxiv, 2024.06. 26.600825, 2024 | | 2024 |
| Of dogs and men. Tracing immune checkpoint signatures across cancers and unleashing the potential of canine PD-1 antibodies M Kocikowski International Centre for Cancer Vaccine Science, 2023 | | 2023 |
| Multi-omics integration in Esophageal Adenocarcinoma reveals therapeutic targets and EAC-specific regulation of protein abundances JR O’Neill, MY Mayordomo, G Mitulović, S Al Shboul, G Bedran, J Faktor, ... medRxiv, 2022.11. 24.22281691, 2022 | | 2022 |
| Development of caninized monoclonal antibodies against PD1 M Kocikowski, K Dziubek, B Vojtesek, D Argyle, T Hupp, M Parys Cancer Research 80 (16_Supplement), 2234-2234, 2020 | | 2020 |
| Investigating tumor intrinsic PD-1/PD-L1 signaling in canine osteosarcoma cell lines as a spontaneous model for human disease D Katarzyna, M Kocikowski, B Vojtesek, D Argyle, M Lisowska, T Hupp, ... Cancer Research 80 (16_Supplement), 5637-5637, 2020 | | 2020 |
| Dogizing Antibodies Against PD1 and CD20 M Kocikowski, T Hupp, D Argyle, M Parys International Centre for Cancer Vaccine Science, 2019 | | 2019 |
Maciej ParysClinical Lecturer在 ed.ac.uk 的电子邮件经过验证
